In fact, we have shown that inhibition of p53 expression in human and murine lung cancer cells leads to enhanced NF-κB activity and likewise, that expression of p53 in p53 null H358 cells reduces NF-κB activity (Fig.3). The gene discussed is NFKB1; the disease is lung carcinoma.